SUBSCRIBE
SUBSCRIBE
News   FDA

Actelion Ltd.'s (JOBS) Tracleer Gets US Approval for Wider Use

August 10, 2009 | 
1 min read
Bookmark and Share

Reuters -- Europe's biggest biotech company Actelion Ltd said on Monday its Tracleer drug had been granted approval for mildly symptomatic pulmonary arterial hypertension (PAH).
FDA Approvals
MORE ON THIS TOPIC
FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)
Government
Signs of Frustration Build Between Kennedy and FDA Commissioner Makary
November 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Rare diseases
FDA Unwraps ‘Plausible Mechanism Pathway’ for Personalized Therapies
November 13, 2025
 · 
3 min read
 · 
Tristan Manalac
Illustration of businessman running back around
Job Trends
When, Not If: Job Market Should Start Turning Around in Next Year or So, Experts Say
November 13, 2025
 · 
6 min read
 · 
Angela Gabriel
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker